Analytical Data
-
Gene name
ALK-1
- Application
-
Alternative Names
ACVRL1; ACVRLK1; HHT2; ORW2; SKR3; TSR-I; TGF-B superfamily receptor type I; Activin A Receptor Type II-Like 1; Serine/Threonine-Protein Kinase Receptor R3
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 85% as determined by SDS-PAGE.
-
Uniprot
P37023
-
Expression Region
Asp22~Gln118
-
Protein Length
Partial
-
Molecular Weight
18kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
ALK-1, or activin receptor-like kinase 1, is a type I receptor that plays a crucial role in various biological processes, including angiogenesis, endothelial cell function, and vascular homeostasis. Research has shown that ALK-1 is primarily involved in the transforming growth factor-beta (TGF-β) signaling pathway, influencing vascular development and repair. Dysregulation of ALK-1 has been implicated in several pathological conditions, including pulmonary arterial hypertension and hereditary hemorrhagic telangiectasia, highlighting its significance as a therapeutic target. The recombinant form of ALK-1 protein has garnered interest in scientific studies due to its potential applications in regenerative medicine and vascular biology. By generating ALK-1 recombinant protein, researchers aim to explore its biological functions, assess its interactions with other signaling molecules, and evaluate its potential as a biomarker or therapeutic agent. Such studies may facilitate a better understanding of vascular diseases and lead to novel treatment strategies.
